Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)
CNY 21.0
(0.92%)
CNY 21.0
(0.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.45 Billion CNY | -3.56% |
| 2022 | 4.61 Billion CNY | 189.57% |
| 2021 | 1.59 Billion CNY | -2.66% |
| 2020 | 1.63 Billion CNY | 52.84% |
| 2019 | 1.07 Billion CNY | 20.22% |
| 2018 | 891.92 Million CNY | 40.16% |
| 2017 | 636.33 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.56 Billion CNY | -1.73% |
| 2024 Q1 | 4.64 Billion CNY | 4.19% |
| 2024 Q3 | 4.49 Billion CNY | -1.4% |
| 2023 Q4 | 4.45 Billion CNY | 0.1% |
| 2023 Q3 | 4.45 Billion CNY | -4.3% |
| 2023 FY | 4.45 Billion CNY | -3.56% |
| 2023 Q2 | 4.65 Billion CNY | -0.06% |
| 2023 Q1 | 4.65 Billion CNY | 0.74% |
| 2022 Q3 | 4.67 Billion CNY | -1.57% |
| 2022 Q4 | 4.61 Billion CNY | -1.17% |
| 2022 FY | 4.61 Billion CNY | 189.57% |
| 2022 Q2 | 4.74 Billion CNY | -1.3% |
| 2022 Q1 | 4.81 Billion CNY | 201.58% |
| 2021 Q4 | 1.59 Billion CNY | -2.05% |
| 2021 Q2 | 1.61 Billion CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 1.59 Billion CNY | -2.66% |
| 2021 Q3 | 1.62 Billion CNY | 1.08% |
| 2020 Q4 | 1.63 Billion CNY | 0.0% |
| 2020 FY | 1.63 Billion CNY | 52.84% |
| 2020 Q2 | 1.92 Billion CNY | 0.0% |
| 2019 FY | 1.07 Billion CNY | 20.22% |
| 2018 FY | 891.92 Million CNY | 40.16% |
| 2017 FY | 636.33 Million CNY | 0.0% |